AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16906020 — intervention group
Group type: EXPERIMENTAL
Intervention: Less than three copies of MDR-1 polymorphisms (T-129C, C3435T, G2677T)
Number of subjects: 44
Study 16906020 — intervention group
Group type: COMPARATOR
Intervention: Control group (Cyp3A5*3 homozygotes)
Number of subjects: 44
Study 12802024 — intervention group
Group type: COMPARATOR
Intervention: COPP-ABVD
Number of subjects: 1195
Study 12802024 — intervention group
Group type: COMPARATOR
Intervention: BEACOPP
Number of subjects: 1195
Study 12802024 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased-dose BEACOPP
Number of subjects: 1195
Study 10814923 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits
Number of subjects: 39
Study 10814923 — intervention group
Group type: COMPARATOR
Intervention: Non-coated circuits
Number of subjects: 39
Study 9616817 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine nebulization at 5 mg (A5)
Number of subjects: 13
Study 9616817 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol nebulization at 5 mg (S)
Number of subjects: 13
Study 9616817 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine nebulization at 2 mg (A2)
Number of subjects: 13
Study 9616817 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine nebulization (A5)
Number of subjects: 13
Study 1356117 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (0.4 mg at 8 AM and 8 PM)
Number of subjects: 17
Study 1356117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol (20 mg at 8 PM)
Number of subjects: 17
Study 1356117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 3935372 — intervention group
Group type: EXPERIMENTAL
Intervention: NORPLANT (six capsules)
Number of subjects: 0
Study 3935372 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered rods (six rods)
Number of subjects: 0
Study 3935372 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31517134 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 0
Study 31517134 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 29124773 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange beverage (OB)
Number of subjects: 30
Study 27123784 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin plus Metformin (20 mg atorvastatin daily plus 500 mg metformin twice daily)
Number of subjects: 130
Study 27123784 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 mg atorvastatin daily)
Number of subjects: 130
Study 24856229 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support (PS) 20 cm H2O + PEEP 0 cm H2O (setting-1)
Number of subjects: 8
Study 24856229 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support (PS) 15 cm H2O + PEEP 5 cm H2O (setting-2)
Number of subjects: 8
Study 21918802 — intervention group
Group type: EXPERIMENTAL
Intervention: Alumina ceramic bearings (144 hips)
Number of subjects: 189
Study 21918802 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-polyethylene bearings (72 hips)
Number of subjects: 189
Study 20649686 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, patient-centered interview conducted by trained health professionals.
Number of subjects: 313
Study 20649686 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 313
Study 18725614 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of oral anticoagulant therapy after 6 months
Number of subjects: 600
Study 18725614 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulant therapy (5-7 months after initiation)
Number of subjects: 600
Study 15920039 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 26
Study 15920039 — intervention group
Group type: COMPARATOR
Intervention: Current therapy (two or three shots per day using NPH insulin and rapid-acting analog)
Number of subjects: 26
Study 12885745 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (5 mg/d increased to 10 mg/d after 4 weeks)
Number of subjects: 63
Study 12885745 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 63
Study 10561302 — intervention group
Group type: EXPERIMENTAL
Intervention: Short interval (SI) group: surgery within 2 weeks after completion of radiation therapy
Number of subjects: 201
Study 10561302 — intervention group
Group type: COMPARATOR
Intervention: Long interval (LI) group: surgery 6 to 8 weeks after completion of radiation therapy
Number of subjects: 201
Study 7995909 — intervention group
Group type: EXPERIMENTAL
Intervention: Gore-Tex sling treatment (alone or in combination with prolapsus cure)
Number of subjects: 72
Study 7995909 — intervention group
Group type: EXPERIMENTAL
Intervention: Gore-Tex sling treatment
Number of subjects: 72
Study 2646849 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 19
Study 2646849 — intervention group
Group type: COMPARATOR
Intervention: Gallamine
Number of subjects: 19
Study 5394178 — intervention group
Group type: COMPARATOR
Intervention: Traditional intermenstrual insertion
Number of subjects: 1486
Study 5394178 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-abortion insertion
Number of subjects: 1486
Study 5394178 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum insertion
Number of subjects: 1486
Study 31090348 — intervention group
Group type: EXPERIMENTAL
Intervention: P-PRP (2.5 mL injected at the bone graft site)
Number of subjects: 36
Study 31090348 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRP (2.5 mL injected at the bone graft site)
Number of subjects: 36
Study 31090348 — intervention group
Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 36
Study 31090348 — intervention group
Group type: EXPERIMENTAL
Intervention: P-PRP
Number of subjects: 36
Study 31090348 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRP
Number of subjects: 36
Study 31090348 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 28341018 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaping Healthy Choices Program (SHCP)
Number of subjects: 30
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Abdominal Hysterectomy from Infraumbilical Median Laparotomy (AHL)
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Hysterectomy from Suprapubic Transverse Incision (AH)
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy with Colpectomy
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications in AH group
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications in TLH group
Number of subjects: 163
Study 24635370 — intervention group
Group type: EXPERIMENTAL
Intervention: AHL and LAVH complications
Number of subjects: 163
Study 22920051 — intervention group
Group type: EXPERIMENTAL
Intervention: Home at Hospital (HaH) care
Number of subjects: 9
Study 22920051 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital care
Number of subjects: 9
Study 19918197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion (DF) shoes
Number of subjects: 21
Study 18191149 — intervention group
Group type: EXPERIMENTAL
Intervention: Ataxia Functional Composite Scale (AFCS)
Number of subjects: 0
Study 18191149 — intervention group
Group type: COMPARATOR
Intervention: Buspirone
Number of subjects: 0
Study 15653650 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-seeking radiopharmaceuticals
Number of subjects: 0
Study 12535753 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate intervention (not specified dosage or duration)
Number of subjects: 134
Study 10433131 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined psychoeducational and cognitive treatment including key-person counselling
Number of subjects: 191
Study 10433131 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 191
Study 8688757 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg or 40 mg daily
Number of subjects: 621
Study 8688757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 621
Study 8688757 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 621
Study 1424414 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg per day)
Number of subjects: 0
Study 2870547 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (100 mg per day in two doses)
Number of subjects: 10
Study 2870547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30184181 — intervention group
Group type: EXPERIMENTAL
Intervention: TOL-463 vaginal insert
Number of subjects: 106
Study 30184181 — intervention group
Group type: EXPERIMENTAL
Intervention: TOL-463 vaginal gel
Number of subjects: 106
Study 30184181 — intervention group
Group type: EXPERIMENTAL
Intervention: TOL-463 (both forms)
Number of subjects: 106
Study 28183146 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal ultrasound monitoring, interdisciplinary team approach, planned delivery through cesarean section, postnatal coverage of the intestine with a silastic bag, first intervention within the first 6 hours after birth, attempt of primary abdominal wall closure, perioperative antibiotic treatment.
Number of subjects: 89
Study 28183146 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal therapy, preterm delivery, lack of abdominal pressure monitoring.
Number of subjects: 89
Study 27876742 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromidin therapy (1.5 month-long course) in addition to standard treatment
Number of subjects: 50
Study 27876742 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without Neuromidin
Number of subjects: 50
Study 25146127 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 60
Study 25146127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23181667 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (within 72 hours after randomization)
Number of subjects: 266
Study 23181667 — intervention group
Group type: COMPARATOR
Intervention: Interval laparoscopic cholecystectomy (25 to 30 days after randomization)
Number of subjects: 266
Study 23181667 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 266
Study 23181667 — intervention group
Group type: COMPARATOR
Intervention: Interval laparoscopic cholecystectomy
Number of subjects: 266
Study 20102891 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 5745
Study 17016799 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodynamic investigation
Number of subjects: 66
Study 17016799 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal ultrasound
Number of subjects: 66
Study 17016799 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between urodynamics and perineal ultrasound
Number of subjects: 66
Study 15863535 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention including partner participation
Number of subjects: 304
Study 15863535 — intervention group
Group type: COMPARATOR
Intervention: Brief intervention without partner participation
Number of subjects: 304
Study 15863535 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner participation in brief intervention
Number of subjects: 304
Study 12177686 — intervention group
Group type: COMPARATOR
Intervention: Galantamine 16 mg/day
Number of subjects: 0
Study 12177686 — intervention group
Group type: COMPARATOR
Intervention: Galantamine 24 mg/day
Number of subjects: 0
Study 12177686 — intervention group
Group type: COMPARATOR
Intervention: Galantamine 24 mg/day for 12 months
Number of subjects: 0
Study 12177686 — intervention group
Group type: COMPARATOR
Intervention: Galantamine (both dosages)
Number of subjects: 0
Study 12177686 — intervention group
Group type: COMPARATOR
Intervention: Galantamine
Number of subjects: 0
Study 10445961 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone SCID for major depression
Number of subjects: 41
Study 10445961 — intervention group
Group type: COMPARATOR
Intervention: In-person SCID for major depression
Number of subjects: 41
Study 10445961 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone SCID for simple phobia
Number of subjects: 41
Study 10445961 — intervention group
Group type: COMPARATOR
Intervention: In-person SCID for simple phobia
Number of subjects: 41
Study 10445961 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone SCID for social phobia
Number of subjects: 41
Study 10445961 — intervention group
Group type: COMPARATOR
Intervention: In-person SCID for social phobia
Number of subjects: 41
Study 10445961 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall agreement for specific lifetime diagnoses
Number of subjects: 41
Study 7549892 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte‐macrophage colony‐stimulating factor
Number of subjects: 0
Study 7549892 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony‐stimulating factor
Number of subjects: 0
Study 7549892 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 0
Study 7549892 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth factor mobilized peripheral blood stem cells
Number of subjects: 0
Study 2012294 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block
Number of subjects: 54
Study 2012294 — intervention group
Group type: COMPARATOR
Intervention: Local wound infiltration
Number of subjects: 54
Study 7059442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine 0.1 mg
Number of subjects: 19
Study 7059442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine 0.3 mg
Number of subjects: 19
Study 7059442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine 0.6 mg
Number of subjects: 19
Study 7059442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine (mean threshold dose)
Number of subjects: 19
Study 7059442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine
Number of subjects: 19
Study 30985996 — intervention group
Group type: EXPERIMENTAL
Intervention: 1975 Japanese diet (JD)
Number of subjects: 60
Study 28629250 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (500 mg twice daily)
Number of subjects: 77
Study 28629250 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 (40 mg twice daily)
Number of subjects: 77
Study 28629250 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily)
Number of subjects: 77
Study 26684319 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 96
Study 26684319 — intervention group
Group type: COMPARATOR
Intervention: Control (no zinc supplementation)
Number of subjects: 96
Study 25043221 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandolean training (intervention)
Number of subjects: 21
Study 25043221 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 21
Study 25043221 — intervention group
Group type: COMPARATOR
Intervention: Both arms (intervention and control)
Number of subjects: 21
Study 23074203 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact Lens (CL)
Number of subjects: 0
Study 23074203 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraocular Lens (IOL)
Number of subjects: 0
Study 18804877 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 123
Study 18804877 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (control)
Number of subjects: 123
Study 18298032 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 month individualised exercise programme using a purpose built dialysis exercise machine
Number of subjects: 22
Study 15665015 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline AMH serum concentrations
Number of subjects: 80
Study 15665015 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 AMH serum concentrations
Number of subjects: 80
Study 15665015 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 AMH
Number of subjects: 80
Study 15665015 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 estradiol
Number of subjects: 80
Study 15665015 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal AMH and day 5 AMH or estradiol measurements
Number of subjects: 80
Study 11827510 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11258740 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 118
Study 11258740 — intervention group
Group type: COMPARATOR
Intervention: Usual community services
Number of subjects: 118
Study 8829791 — intervention group
Group type: EXPERIMENTAL
Intervention: Allowances and forgivable loans to raise them above the poverty line for one year.
Number of subjects: 54
Study 8829791 — intervention group
Group type: COMPARATOR
Intervention: Some funds, but not enough to raise them above the poverty line.
Number of subjects: 54
Study 2081722 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg or 1000 mg bd)
Number of subjects: 6
Study 2081722 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (rifampicin plus doxycycline)
Number of subjects: 6
Study 370367 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetylo-salicylate (2 g per os) during heat exposure at 37 degrees C
Number of subjects: 10
Study 370367 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetylo-salicylate (2 g per os) during exercise at 25 degrees C
Number of subjects: 10
Study 370367 — intervention group
Group type: COMPARATOR
Intervention: Placebo during heat exposure at 37 degrees C
Number of subjects: 10
Study 370367 — intervention group
Group type: COMPARATOR
Intervention: Placebo during exercise at 25 degrees C
Number of subjects: 10
Study 31696741 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 60
Study 31696741 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 60
Study 28969434 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing stretch velocity method
Number of subjects: 10
Study 28969434 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing stretch velocity method
Number of subjects: 10
Study 28969434 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised stretch velocity method
Number of subjects: 10
Study 28969434 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic stretch reflex threshold (TSRT) measurement
Number of subjects: 10
Study 28930959 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI + HS
Number of subjects: 670
Study 28930959 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI
Number of subjects: 670
Study 28930959 — intervention group
Group type: COMPARATOR
Intervention: HS
Number of subjects: 670
Study 28930959 — intervention group
Group type: COMPARATOR
Intervention: Neither group
Number of subjects: 670
Study 28930959 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI + HS and TBI
Number of subjects: 670
Study 28930959 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI + HS or TBI
Number of subjects: 670
Study 25864611 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D concentrations
Number of subjects: 1009
Study 25864611 — intervention group
Group type: COMPARATOR
Intervention: Control group (better educated participants)
Number of subjects: 1009
Study 23219660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (Arm 3)
Number of subjects: 1693
Study 23219660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab in cycles 2-6 only (Arm 2)
Number of subjects: 1693
Study 23219660 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Arm 1)
Number of subjects: 1693
Study 21965475 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose epirubicin plus cyclophosphamide (EC) - E 120 mg/m², C 600 mg/m² for four cycles every 21 days
Number of subjects: 750
Study 21965475 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (D) 100 mg/m² followed by four cycles of EC for four cycles every 21 days
Number of subjects: 750
Study 19244153 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 434
Study 19244153 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition supplementation
Number of subjects: 434
Study 19244153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study 17328643 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical orthopedics (PSO)
Number of subjects: 50
Study 17328643 — intervention group
Group type: COMPARATOR
Intervention: No presurgical orthopedics (No PSO)
Number of subjects: 50
Study 15117298 — intervention group
Group type: EXPERIMENTAL
Intervention: 2RE(3)HZ(3)(alt)/4RH(2) (split I)
Number of subjects: 1240
Study 15117298 — intervention group
Group type: EXPERIMENTAL
Intervention: 3RE(3)HZ(3)(alt)/3RH(2) (split II)
Number of subjects: 1240
Study 15117298 — intervention group
Group type: COMPARATOR
Intervention: 2REHZ(3)/4RH(2) (control)
Number of subjects: 1240
Study 11846927 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative external beam radiation therapy
Number of subjects: 301
Study 9751087 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 at 3 or 10 mg/kg with or without MTX
Number of subjects: 101
Study 9751087 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 at 1 mg/kg without MTX
Number of subjects: 101
Study 9751087 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 at 1 mg/kg with MTX
Number of subjects: 101
Study 9751087 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus low-dose MTX
Number of subjects: 101
Study 9751087 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 at 10 mg/kg with MTX
Number of subjects: 101
Study 9751087 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 at 1 mg/kg alone
Number of subjects: 101
Study 8176574 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin suspension at 3.75, 7.5, and 15 mg/kg per dose every 12 hours
Number of subjects: 25